Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues
Operating Expenses:
Personnel costs	122,458	91,502
Research and development expenses, related party	13,097	17,698
Professional fees	448,806	191,881
Impairment loss	340,231
General and administrative expenses	60,198	35,790
Total operating expenses	984,790	336,871
Loss from operations	(984,790)	(336,871)
Other income:
Other income		100,000
Total other income		100,000
Loss before income taxes	(984,790)	(236,871)
Income taxes
Net loss available to common shareholders	(984,790)	(236,871)
Deemed dividend on warrant modification	(3,548)
Net loss available to common stockholders	$ (988,338)	$ (236,871)
Net loss per common share:
Basic and diluted	$ (0.03)	$ (0.01)
Weighted average common shares outstanding:
Basic and diluted	30,577,988	17,656,762